Follow the Pundits: When Institutional Trades Matter | Funanc1al – tagged "Bausch Health"

Follow the Pundits

Tag: Bausch Health

A glowing gold bar with rising stock charts and biotech symbols, representing John Paulson’s concentrated investment strategy in gold and healthcare.

March 30, 2026

John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀

A hyper-concentrated portfolio, a $5,000 gold target, and massive biotech bets—John Paulson is back with one of the boldest strategies in markets today.

Read entire article

Tags: 13F Filings, Bausch Health, Biotech Stocks, Biotech Stocks 2026, featured-hedge-funds, FUNanc1al stocks, gold investing, gold miners, hedge funds, high conviction investing, hub-hedge, John Paulson, macro investing, Madrigal Pharmaceuticals, Perpetua Resources, portfolio analysis

Futuristic medical-pharma cityscape with glowing capsules, rising stock arrows, and a giant magnifying glass over Bausch Health, symbolizing deep-value investing and insider buying.

November 30, 2025

Paulson & Co Keeps Adding to His Bausch Health Stake: Should Investors See Eye to Eye With Him?

Billionaire John Paulson now owns nearly 19% of Bausch Health — and he keeps buying. With improving earnings, low valuation, and high risk, BHC may be a speculative value play worth watching.

Read entire article

Tags: Bausch Health, BHC Stock, Buy or sell BHC, contrarian investing, Contrarian Investment, ContrarianStocks, Debt Risk, featured-hedge-funds, featured-overseas, Funanc1al Edge, FUNanc1al Health Hub, Funanc1al Humor, FUNanc1al Investing, FUNanc1al Stocks & Fun, hub-insiders, Insider Buying, John Paulson, Paulson & Co, Pharma Stocks, Risks Investing in BHC, Turnaround Stories, Value Stocks, Why Buy BHC

Your cart

Follow the Pundits

Tag: Bausch Health

March 30, 2026

John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀

November 30, 2025

Paulson & Co Keeps Adding to His Bausch Health Stake: Should Investors See Eye to Eye With Him?

Quick links

Contact us

About us

Follow us